FDA
FDA and European Union expand Mutual Recognition Agreement to include animal drugs
The joint decision to expand the MRA's Sectoral Annex for Pharmaceutical Good Manufacturing Practices is a step toward strengthening use of each other’s animal drug inspection expertise and resources
Drug for acute onset of canine pancreatitis is launched on the US market
Conditionally approved by the FDA, fuzapladib sodium for injection is a leukocyte function-associated antigen-1 activation inhibitor.
FDA approves first monoclonal antibody for managing OA pain in dogs
Zoetis’ bedinvetmab injection is a prescription solution targeting canine nerve growth factor.
FDA conditionally approves first drug for anemia in cats
The first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats
New broad-spectrum parasite protection for cats receives FDA approval
The NexGard COMBO topical solution from Boehringer Ingelheim helps prevent tapeworms and other intestinal parasites as well as fleas, ticks, and heartworms.
4 recent FDA updates
The most recent first-time generic drug approvals by the FDA
Generic corticosteroid for dogs, cats and horses receives FDA approval
Bimasone Injectable Solution is a corticosteroid drug that contains flumethasone in the same concentration and dosage form as Flucort.
First generic maropitant citrate tablets for dogs receive FDA approval
This newly approved drug will help prevent acute vomiting and vomiting due to motion sickness
FDA approves first generic moxidectin injectable solution for cattle parasite treatment
Tauramox is the first generic moxidectin injectable solution to control internal and external parasites
FDA approves generic drug for managing allergic dermatitis in cats
Modulis for Cats by Provetica contains the same active ingredient in the same concentration and dosage form as the Atopica for Cats brand product.